Vellanki Avanish 4
4 · Rain Therapeutics Inc. · Filed Feb 4, 2022
Insider Transaction Report
Form 4
Vellanki Avanish
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+182,300→ 182,300 totalExercise: $8.02Exp: 2032-02-02→ Common Stock (182,300 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 182,300 shares of the Issuer's common stock, one quarter of which will vest on February 2, 2023, with the remaining three quarters vesting in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to the Issuer.